» Articles » PMID: 36228916

East Africa International Center of Excellence for Malaria Research: Summary of Key Research Findings

Abstract

The Program for Resistance, Immunology, Surveillance, and Modeling of Malaria (PRISM) has been conducting malaria research in Uganda since 2010 to improve the understanding of the disease and measure the impact of population-level control interventions in the country. Here, we will summarize key research findings from a series of studies addressing routine health facility-based surveillance, comprehensive cohort studies, studies of the molecular epidemiology, and transmission of malaria, evaluation of antimalarial drug efficacy, and resistance across the country, and assessments of insecticide resistance. Among our key findings are the following. First, we found that in historically high transmission areas of Uganda, a combination of universal distribution of long-lasting insecticidal-treated nets (LLINs) and sustained indoor residual spraying (IRS) of insecticides lowered the malaria burden greatly, but marked resurgences occurred if IRS was discontinued. Second, submicroscopic infections are common and key drivers of malaria transmission, especially in school-age children (5-15 years). Third, markers of drug resistance have changed over time, with new concerning emergence of markers predicting resistance to artemisinin antimalarials. Fourth, insecticide resistance monitoring has demonstrated high levels of resistance to pyrethroids, appreciable impact of the synergist piperonyl butoxide to pyrethroid susceptibility, emerging resistance to carbamates, and complete susceptibility of malaria vectors to organophosphates, which could have important implications for vector control interventions. Overall, PRISM has yielded a wealth of information informing researchers and policy-makers on the malaria burden and opportunities for improved malaria control and eventual elimination in Uganda. Continued studies concerning all the types of surveillance discussed above are ongoing.

Citing Articles

mosquito exposure is associated with age, gender and bed net use in areas in Uganda experiencing varying malaria transmission intensity.

Blanken S, Kilama M, Ramjith J, Musiime A, Lanke K, Ayo D medRxiv. 2024; .

PMID: 39711707 PMC: 11661323. DOI: 10.1101/2024.12.12.24318757.


Dramatic resurgence of malaria after 7 years of intensive vector control interventions in Eastern Uganda.

Kamya M, Nankabirwa J, Arinaitwe E, Rek J, Zedi M, Maiteki-Sebuguzi C PLOS Glob Public Health. 2024; 4(8):e0003254.

PMID: 39208072 PMC: 11361418. DOI: 10.1371/journal.pgph.0003254.


Immune cell phenotype and function patterns across the life course in individuals from rural Uganda.

Nalwoga A, Nakibuule M, Roshan R, Kwizera Mbonye M, Miley W, Whitby D Front Immunol. 2024; 15:1356635.

PMID: 38562926 PMC: 10982424. DOI: 10.3389/fimmu.2024.1356635.


Dramatic resurgence of malaria after 7 years of intensive vector control interventions in Eastern Uganda.

Kamya M, Nankabirwa J, Arinaitwe E, Rek J, Zedi M, Maiteki-Sebuguzi C medRxiv. 2024; .

PMID: 38559091 PMC: 10980127. DOI: 10.1101/2024.03.15.24304352.

References
1.
Quinones M, Norris D, Conn J, Moreno M, Burkot T, Bugoro H . Insecticide Resistance in Areas Under Investigation by the International Centers of Excellence for Malaria Research: A Challenge for Malaria Control and Elimination. Am J Trop Med Hyg. 2015; 93(3 Suppl):69-78. PMC: 4574276. DOI: 10.4269/ajtmh.14-0844. View

2.
Dorsey G, Kamya M, Singh A, Rosenthal P . Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis. 2001; 183(9):1417-20. DOI: 10.1086/319865. View

3.
Katrak S, Nayebare P, Rek J, Arinaitwe E, Nankabirwa J, Kamya M . Clinical consequences of submicroscopic malaria parasitaemia in Uganda. Malar J. 2018; 17(1):67. PMC: 5800031. DOI: 10.1186/s12936-018-2221-9. View

4.
Miller R, Hathaway N, Kharabora O, Mwandagalirwa K, Tshefu A, Meshnick S . A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity. Malar J. 2017; 16(1):490. PMC: 5732508. DOI: 10.1186/s12936-017-2137-9. View

5.
Dorsey G, Kamya M, Ndeezi G, Babirye J, Phares C, Olson J . Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg. 2001; 62(6):686-92. DOI: 10.4269/ajtmh.2000.62.686. View